Raje, N.S. Moreau, P. Terpos, E. Benboubker, L. Grząśko, N. Holstein, S.A. Oriol, A. Huang, S.-Y. Beksac, M. Kuliczkowski, K. Tai, D.F. Wooldridge, J.E. Conti, I. Kaiser, C.J. Nguyen, T.S. Cronier, D.M. Palumbo, A., Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma, British Journal of Haematology, (176), 783-795, 2017, Wiley-Blackwell Publishing Ltd, 0007-1048, 1365-2141